|
Separation of Nitrosamines and Ranitidine
|
|
3
|
177
|
May 27, 2025
|
|
N-nitroso Torasemide Impurity formation and control
|
|
33
|
2255
|
May 27, 2025
|
|
Cleaning procedure for glassware used in the analysis of nitrosamines for LC-MS/MS
|
|
2
|
269
|
May 23, 2025
|
|
N-Nitrosamine impurity of heterocyclic aromatic ring
|
|
17
|
3638
|
May 13, 2025
|
|
Total Nitrosamine Analyzer
|
|
3
|
198
|
May 12, 2025
|
|
Health Canada: Nitrosamine impurities Update July 26, 2024
|
|
16
|
1431
|
May 9, 2025
|
|
MDD for Metformin
|
|
4
|
230
|
May 2, 2025
|
|
🇰🇷 Korea NRA on 'Case Studies on Reducing Impurities in Pharmaceuticals (focusing on NDMA)"
|
|
0
|
283
|
May 1, 2025
|
|
Autonomous CPCA Web-based calculator FREE
|
|
33
|
5937
|
April 30, 2025
|
|
N-nitrosoamides - a horse of a different color
|
|
54
|
6423
|
March 6, 2025
|
|
To which nitrosamines does the CPCA apply?
|
|
2
|
462
|
February 6, 2025
|
|
What is CPCA Score for “N-nitroso of 3-Amino-1,2,4-triazole"
|
|
7
|
430
|
January 30, 2025
|
|
Acceptable Intake N-Nitrosobiotin (N-Nitrosamide)
|
|
2
|
236
|
January 13, 2025
|
|
Development of a Simultaneous Analytical Method for Amines Corresponding to 10 Typical Nitrosamines
|
|
0
|
598
|
December 30, 2024
|
|
Formation of Nitroso-Omeprazole
|
|
5
|
1910
|
December 12, 2024
|
|
Hexamethyldisilazane (HMDS) can form Nitrosamine Impurity?
|
|
7
|
537
|
October 29, 2024
|
|
Primeros pasos para evaluar nitrosaminas en medicamentos
|
|
5
|
235
|
September 23, 2024
|
|
N-Nitroso Carbidopa
|
|
2
|
356
|
September 12, 2024
|
|
Can API with amide should considered a potential candidate for forming nitrosamine impurity
|
|
5
|
415
|
September 12, 2024
|
|
Potential Topic for an event concerning obtaining the right level of Nitrosamine Risk Assessment information from your CMOs
|
|
22
|
1658
|
September 5, 2024
|
|
N-nitroso-rivaroxaban amide
|
|
6
|
1546
|
August 29, 2024
|
|
How much Amine and Nitrating agent "Stoichiometric Ratio" required for formation of Nitrosamine impurities?
|
|
3
|
242
|
August 28, 2024
|
|
DMF in API, specification limit in formulation
|
|
5
|
786
|
August 26, 2024
|
|
Nitrosamine impurities of related substances of API's
|
|
7
|
859
|
August 12, 2024
|
|
N-nitroso Omeprazole
|
|
4
|
1540
|
August 3, 2024
|
|
Control limit of Nitrosamines and N-nitroso compounds
|
|
2
|
470
|
July 8, 2024
|
|
Non-mutagenic, carcinogenic impurities
|
|
3
|
560
|
June 30, 2024
|
|
MEGLUMINE (Methylglucamine)
|
|
18
|
2771
|
June 19, 2024
|
|
Tetrazole nitrosamines
|
|
1
|
291
|
June 13, 2024
|
|
Update: EFPIA workflows for Quality Risk management Jun 2024 v03
|
|
2
|
939
|
June 4, 2024
|